Low‐risk oncocytic renal neoplasm: A useful cytologic diagnosis
Cancer Cytopathology · 2024-02 · 132 (2) · 84-86
DOI: 10.1002/cncy.22748 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cytopathology, online erschienen am 31.07.2023. Verfasst von Andrew A Renshaw und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Baptist Hospital and Miami Cancer Institute, Miami, Florida, USA. Hauptthemen laut MEDLINE: Adenoma, Oxyphilic, Kidney Neoplasms, Carcinoma, Renal Cell. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
The proposed diagnostic category of “low‐risk oncocytic renal neoplasm” consists of both oncocytomas and a subset of chromophobe renal cell carcinomas but has a 5‐year survival of at least 95%–100%.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pathology, Baptist Hospital and Miami Cancer Institute, Miami, Florida, USA.
- Department of Pathology, University of Miami Miller School of Medicine, Miami, Florida, USA.
- Department of Pathology, Loyola University Medical Center, Chicago, Illinois, USA.
- Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Andrew A Renshaw
Zitieren
APA
Renshaw, A. A., Jorda, M., Wojcik, E. M., & Pitman, M. B. (2024). Low‐risk oncocytic renal neoplasm: A useful cytologic diagnosis. Cancer Cytopathology, 132(2), 84-86. https://doi.org/10.1002/cncy.22748
Vancouver
Renshaw AA, Jorda M, Wojcik EM, Pitman MB. Low‐risk oncocytic renal neoplasm: A useful cytologic diagnosis. Cancer Cytopathology. 2024;132(2):84-86. doi:10.1002/cncy.22748
BibTeX
@article{Renshaw2024,
author = {Renshaw, Andrew A and Jorda, Merce and Wojcik, Eva M and Pitman, Martha B},
title = {Low‐risk oncocytic renal neoplasm: A useful cytologic diagnosis},
journal = {Cancer Cytopathology},
year = {2024},
volume = {132},
number = {2},
pages = {84--86},
doi = {10.1002/cncy.22748}
}
EUVIMED